Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial

INTRODUCTION: Atopic dermatitis (AD), with its signs and symptoms of pruritus, dryness, and erythema, severely reduces the quality of life (QOL) of affected patients. We investigated the impact of nemolizumab 60 mg on QOL in Japanese patients aged ≥ 13 years with AD and inadequately controlled moder...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabashima, Kenji, Matsumura, Takayo, Komazaki, Hiroshi, Kawashima, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060612/
https://www.ncbi.nlm.nih.gov/pubmed/36905481
http://dx.doi.org/10.1007/s13555-023-00901-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060612/
https://www.ncbi.nlm.nih.gov/pubmed/36905481
http://dx.doi.org/10.1007/s13555-023-00901-7

Ejemplares similares